Transcribed
Personal journeys and hard-earned lessons behind biotech’s biggest breakthroughs
Featured interview
with Andrew Bellinger
Co-founder
Corner Therapeutics
Andrew Bellinger discusses what it takes to build new drug modalities from scratch, the bold bets and tough calls that shaped Verve’s journey, and lessons in building new companies from first-in-class science.
Podcast available on
More stories
Transcribed